Skip to content
China Biologic icon

China Biologic

CBPOStocksBiotechnologyChinaNasdaqUSD

Price

$119.99

Today

+0.0%

YTD

+0.0%

About

China Biologic Products Holdings Inc. (formerly known as China Biologic Products Inc.) is a biopharmaceutical company, focused on researching, developing and marketing over 20 different human plasma-based products across China. Products include: human immunoglobulin, placenta polypeptide, Factor VIII, human prothrombin complex concentrate (PCC), and more. These and many other products are sold directly or through distributors. Also, the company is currently developing additional products, such as Human fibrinogen, Immune Globulin Intravenous, Human coagulation factor IX for hemophilia B patients, and more. Invest in this instrument and stay updated on recent price changes.

Price chart
Closing price history for CBPO (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.

Open positions

0

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)30.40
P/S (TTM)Unknown
P/B (TTM)2.35
Market cap$4.65B
Cap tierMid-cap
Industry avg P/E-2.35

Profitability

Gross margin69.50%
EBIT margin37.25%
Net margin21.14%
ROE8.28%
ROA7.26%

Earnings & Revenue

Revenue (TTM)$524.34M
Revenue growth (1Y)+4.1%
EPS (TTM)$3.95
Free cash flow$247.31M
Total debt$0.00

Dividends & Risk

Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)0.19
Employees2,269
Next earnings20 May '21
Trade history

Closed trades

0

Realized return

+0.0%

No stored closed trades exist for this instrument yet.

China Biologic (CBPO) | Dirk Kuyken